ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO344

Potent Pro-Angiogenic Mediators Fail to Improve the Post-Ischemic Angiogenesis in the Uremic Milieu

Session Information

Category: Hypertension and CVD

  • 1403 Hypertension and CVD: Mechanisms

Authors

  • Arinze, Nkiruka, Boston University Medical Center, Boston, Massachusetts, United States
  • Richards, Sean, Boston University Medical Center, Boston, Massachusetts, United States
  • Napoleon, Marc A., Boston University Medical Center, Boston, Massachusetts, United States
  • Walker, Joshua A., Boston University Medical Center, Boston, Massachusetts, United States
  • Belghasem, Mostafa, Boston University Medical Center, Boston, Massachusetts, United States
  • Lyle, Chimera Lynn, Boston University Medical Center, Boston, Massachusetts, United States
  • Anderson, Stephan, Boston University, Boston, Massachusetts, United States
  • Siracuse, Jeffrey, Boston University Medical Center, Boston, Massachusetts, United States
  • Farber, Alik, Boston University Medical Center, Boston, Massachusetts, United States
  • Rahimi, Nader, Boston University Medical Center, Boston, Massachusetts, United States
  • Chitalia, Vipul C., Boston University Medical Center, Boston, Massachusetts, United States
Background

Patients with chronic kidney disease (CKD) have been shown to have a 3-fold higher prevalence of peripheral arterial disease. Although CKD represents an independent risk factor for PAD, CKD-specific contributors remain unknown. The Wnt/beta catenin pathway is a potent pro-angiogenic pathway that increases endothelial cell proliferation and capillary permeability. Casitas b-cell lymphoma (c-Cbl) is a negative regulator of nuclear active beta catenin. We hypothesized that reduced activity of c-Cbl is likely to augment Wnt/beta catenin signaling in ischemia-induced angiogenesis in the uremic milieu.

Methods

Unilateral hindlimb ischemia (HLI) model was performed in 8-12 week old c-Cbl +/+ and c-Cbl +/- female mice under non-CKD and CKD conditions using the adenine-induced CKD model. Laser Doppler imaging was used to determine perfusion recovery over time. CD31 staining was used to determine capillary density. Capillary leakage was detected by dextran infusion. Both were quantitated as integrated density. Wnt/beta catenin activity was examined in primary human endothelial cells.

Results

On normal diet, c-Cbl+/- mice exhibited higher perfusion, capillary density, endothelial permeability and beta catenin expression in the ligated limb compared to c-Cbl+/+ mice. Adenine diet significantly compromised all of these parameters in both c-Cbl+/- and c-Cbl+/+ mice. Mechanistic probing revealed that the uremic milieu inhibited Wnt activity and the nuclear pool of active beta catenin in the endothelial cells, which was in part driven by P-cresyl sulfate.

Conclusion

This study demonstrates the detrimental effect of uremia on ischemia induced angiogenesis and suppression of Wnt/beta catenin signaling in endothelial cells by specific uremic solutes. These results provide the first potential link of uremic solutes with a potent pro-angiogenic Wnt/beta catenin pathway. This interaction warrants further exploration as a potential CKD-specific mediator of PAD.

 Perfusion Index (Day 14) Integrated density CD31 per micron surface area Integrated density Dextran per micron surface area 
 c-Cbl+/+c-Cbl+/-c-Cbl+/+c-Cbl+/-c-Cbl+/+c-Cbl+/-
Normal Diet0.37 ±0.030.79 ±0.08 (p=0.01)*337.9±49.43849.2±125.4(p=0.01)*87.44±9.71147.9±24.97 (p=0.02)
0.2% Adenine Diet0.26 + 0.07
(p = 0.05)#
0.23 ± 0.2092.40±14.17 (p<0.001)#117.6±10.4651.81±4.99 (p=0.01)#66.84±5.63

*compares both groups on normal diet, #compares c-Cbl+/+ mice on adenine and normal chow

Funding

  • NIDDK Support